Hepatitis B virus (HBV) is a significant cause of
|
|
- Darcy Ferguson
- 5 years ago
- Views:
Transcription
1 Secular Trend of the Viral Genotype Distribution in Children With Chronic Hepatitis B Virus Infection After Universal Infant Immunization Wan-Hsin Wen, 1,6,7 Huey-Ling Chen, 1,2 Yen-Hsuan Ni, 1 Hong-Yuan Hsu, 1,2 Jia-Horng Kao, 3,4,5 Fu-Chang Hu, 3 and Mei-Hwei Chang 1,4,5 Genotypes B and C are the major hepatitis B virus (HBV) genotypes in Taiwan, and genotype C is associated with more severe liver disease than genotype B. Whether the implementation of the hepatitis B immunization program has affected the secular trend of the HBV genotype distribution remains unknown. We thus investigated the HBV genotypes in hepatitis B surface antigen (HBsAg) carrier children born before the implementation of the universal infant immunization program and in those born afterward. One hundred seven children who were infected with HBV despite appropriate immunization were enrolled as immunized cases with HBV breakthrough infection. Each case was matched with two unimmunized HBsAg carriers according to the age at enrollment. HBV genotypes were determined with molecular methods. Compared with unimmunized HBsAg carriers, more immunized children had HBsAg-positive mothers (65.9% versus 100%, P < 0.001) and were infected with genotype C (16.4% versus 42.1%, P < 0.001). Among the children born to HBsAg-positive mothers, the mothers and children s HBV genotypes were highly concordant in both unimmunized [j , 95% confidence interval (CI) ] and immunized children (j , 95% CI ). After adjustments for gender, maternal age, and delivery mode, immunized HBsAg-carrier children born to HBsAg-positive mothers had a higher likelihood of genotype C infection than unimmunized children (odds ratio , 95% CI , P ). However, the increased genotype C to genotype B ratio was not seen in the HBsAg-carrier mother pool in the postimmunization era. Conclusion: In the postimmunization era, most HBV breakthrough infections are due to maternal transmission, and immunized children born to genotype C mothers may have a higher rate of breakthrough infection than those born to genotype B mothers. (HEPATOLOGY 2011;53: ) Abbreviations: CI, confidence interval; HBeAg, hepatitis B e antigen; HBIG, hepatitis B immunoglobulin; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; PCR, polymerase chain reaction; SD, standard deviation; ULN, upper limit of normal. From the Departments of 1 Pediatrics; 2 Primary Care Medicine; 3 Medical Research; 4 Hepatitis Research Center; 5 Graduate Institute of Clinical Medicine, College of Medicine and Hospital, National Taiwan University, Taipei, Taiwan; 6 Department of Pediatrics, Cardinal Tien Hospital, Taipei, Taiwan; and 7 School of Medicine, Fu-Jen Catholic University, Taipei, Taiwan. Received May 31, 2010; accepted October 23, Supported by grants from the National Science Council (NSC B MY3), the National Health Research Institutes (NHRI-EX B1), and the Department of Health of the Executive Yuan (DOH-97- DC-10181). Address reprint requests to: Mei-Hwei Chang, M.D., Department of Pediatrics, College of Medicine and Hospital, National Taiwan University, Taipei, Taiwan. changmh@ntu.edu.tw; fax: Copyright VC 2010 by the American Association for the Study of Liver Diseases. View this article online at wileyonlinelibrary.com. DOI /hep Potential conflict of interest: Nothing to report. Hepatitis B virus (HBV) is a significant cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC) worldwide. 1 In Taiwan, an area hyperendemic for HBV infection, 2 the disease is usually acquired perinatally or in early childhood. 3,4 Since the launch of the universal infant immunization program against HBV in July 1984, the seropositive rate of hepatitis B surface antigen (HBsAg), 5 the incidence/mortality rate of fulminant hepatitis, 6,7 and the incidence rate of HCC 8 in Taiwanese children have all substantially declined. However, the current immunization strategy cannot completely eradicate the transmission of HBV. Approximately 10% of infants born to HBsAg-positive and hepatitis B e antigen (HBeAg) positive mothers are still infected and suffer from chronic hepatitis B. 9,10 In addition, although the overall incidence rate of childhood HCC has declined, HBsAg-carrier children 429
2 430 WEN ET AL. HEPATOLOGY, February 2011 born after the implementation of the immunization program bear a higher risk of developing HCC than those born before the program (risk ratio ¼ ). 11 The factors contributing to HBV breakthrough infection and the subsequent development of HCC in these carrier children remain largely unknown. It is, therefore, important to compare the clinical and virological characteristics of HBsAg-carrier children born before the implementation of hepatitis B immunization program and those born afterward. At least eight HBV genotypes (A-H) have been identified worldwide on the basis of a divergence of 8% or more of the entire nucleotide sequences Before the immunization era, HBV genotype B was the most prevalent genotype in Taiwan and accounted for approximately 80% of HBV strains. Genotype C accounted for the remaining 20%, and the other genotypes were very rare. 16 In addition, in comparison with genotype B, genotype C is associated with a delayed HBeAg seroconversion, a higher viral load, and more severe liver diseases such as cirrhosis and HCC Because a higher maternal viral load leads to a higher likelihood of HBV breakthrough infection in infants, we hypothesized that the HBV genotype associated with a delayed clearance of HBeAg and a higher viral load would result in a higher rate of breakthrough infection. Thus the distribution of HBV genotypes may change in the immunization era. In this study, the secular trend of the HBV genotype distribution was investigated in Taiwanese HBsAg-carrier children born before the implementation of the hepatitis B immunization program and in those born afterward. In addition, because perinatal transmission is an important route of HBV spread in Taiwan, 3 HBV genotypes of HBsAg-positive mothers were also examined. Patients and Methods Universal Hepatitis B Immunization Program In Taiwan, the hepatitis B immunization program beginning at birth was implemented on July 1, After the program was launched, hepatitis B serological tests were compulsory for all pregnant women so infants born to HBsAg-positive mothers could be identified. Initially, the program covered only newborns of HBsAg-positive mothers; it was extended to all newborns after July Before July 1992, four doses of a plasma-derived vaccine (Hevac B, Pasteur-Merieux, Lyon, France) or its equivalent (Lifeguard hepatitis B vaccine, Hsin-Chu, Taiwan) were given at 0, 1, 2, and 12 months of age. After July 1992, three doses of the recombinant vaccine H-B-Vax II (5 lg/0.5 ml; Merck Sharp & Dohme, Rahway, NJ) or Engerix-B (20 lg/ ml; SmithKline Beecham, Rixensart, Belgium) were administered (within the first week of birth, at 1 month of age, and at 6 months of age). For newborns of HBeAg-positive mothers or HBsAg-positive mothers with a high titer of HBsAg (reciprocal titer >1:2560 as confirmed by reverse passive hemagglutination testing), 0.5 ml (100 IU) of hepatitis B immunoglobulin (HBIG) was administered within 24 hours of birth. 10,26 For newborns of HBsAg-positive but HBeAg-negative mothers, the administration of HBIG was optional. Children With Chronic HBV Infection Four hundred seventy-one children who were 15 years of age or younger and had been diagnosed with chronic HBV infection (i.e., they were HBsAg-seropositive for at least 6 months) were recruited. These carrier children were enrolled from (1) the outpatient clinic of National Taiwan University Hospital in a prospective study beginning approximately 3 decades ago, (2) a prospective screening program for carrier children of HBsAg-seropositive mothers, or (3) five cross-sectional studies of a hepatitis B vaccination efficacy survey in 1984, 1989, 1994, 1999, and Informed consent was obtained from the children s parents or guardians. The institutional review board of National Taiwan University Hospital approved the protocol for this study. Immunized Cases With HBV Breakthrough Infection. To identify cases with HBV breakthrough infection despite immunization beginning at birth, we reviewed the hepatitis B immunization histories of the 471 children with chronic HBV infection. The immunization histories were obtained by the transcription of information from the health booklet distributed to each newborn by the Department of Health of Taiwan. We also checked the birth and/or immunization records kept by National Taiwan University Hospital if the subjects had been born or immunized there. Those with an unknown maternal HBsAg status, unclear hepatitis B immunization histories, or inappropriate hepatitis B immunization were excluded from the analysis. Finally, 107 of the 471 children with chronic HBV infection were confirmed to have received appropriate hepatitis B immunization at infancy and thus were designated as immunized cases with HBV breakthrough infection. Age-Matched, Unimmunized HBsAg Carriers. After checking the hepatitis B immunization histories, we
3 HEPATOLOGY, Vol. 53, No. 2, 2011 WEN ET AL. 431 HBV Serology and Serum Aminotransferase Levels The hepatitis B serological markers (HBsAg, antibody against HBsAg, antibody against hepatitis B core antigen, HBeAg, and antibody against HBeAg) were determined by enzyme immunoassays (Abbott Laboratories, North Chicago, IL). The serum alanine aminotransferase levels were measured with an autoanalyzer (model 7450, Hitachi, Tokyo, Japan). Fig. 1. Flowchart of HBsAg-carrier children in the study. identified 337 HBsAg-carrier children who did not receive any hepatitis B immunization. According to the age at enrollment, we divided the immunized and unimmunized HBsAg-carrier children into three groups: 0 to 5 years, 6 to 10 years, and 11 to 15 years. Each immunized case with HBV breakthrough infection was matched with two randomly selected unimmunized carriers from the corresponding age group. The flow of the participants is shown in Fig. 1. HBsAg-Positive Mothers The maternal HBsAg status was checked at the time of the children s enrollment. For children born after the implementation of the immunization program, the prenatal maternal HBsAg/HBeAg status was extracted from records. Serum samples of the HBsAg-positive mothers were collected after their children s enrollment and were stored for HBV genotyping at a later date. In addition, to determine the maternal HBV genotype distribution in the general population in the postimmunization era, HBV genotypes of another 136 HBsAg-positive women who delivered babies from April 2007 to March 2009 at National Taiwan University Hospital were also examined at the time of delivery. HBV Genotyping The serum samples of HBsAg-carrier children were collected upon each subject s enrollment and were stored at 80 C for HBV genotype analysis at a later date. The children s HBV genotypes were determined by polymerase chain reaction (PCR) with genotypespecific primers in the regions of the pre-s1 and S genes. 27 The procedures are described in detail in our previous publication. 19 Maternal HBV genotypes were determined by real-time PCR with subsequent melting curve analysis based on a single nucleotide polymorphism in the X gene as previously described. 28 When the HBV genotype identified in a given child was inconsistent with that identified in his or her mother, direct sequencing of the S gene from both the child and the mother was performed to confirm the genotyping results. The S genes were amplified with the primers 5 0 -ctg-ctg-gtg-gct-cca-gtt-cag-3 0 (sense, position 57-74) and 5 0 -taa-cct-ttc-ata-cag-ttt-ctt-aacacc-cag-aaa-ac-3 0 (antisense, position ). The PCR products were sequenced on both strands with the BigDye Terminator V3.1 cycle sequencing kit (Applied Biosystems, Foster City, CA) with the same primers used for PCR. The sequencing products were analyzed with an ABI 3730xl DNA analyzer (Applied Biosystems). The obtained sequences were aligned with GenBank sequences corresponding to HBV genotypes B and C. The GenBank accession numbers were as follows: AB191369, AB191351, DM059403, CS388974, and CS for genotype B and AB AB113879, AB191350, AB191352, AB191353, AB191357, AB191359, AB191362, AB191365, AB191368, AB191380, and AB for genotype C. BLASTN was used to align sequences and determine genotype identity by means of sequence similarity. 29,30 Statistical Analyses Statistical analyses were performed with Stata 8.2 software (Stata Corp., College Station, TX) and SAS software (SAS Institute, Inc., Cary, NC). Twosided P values 0.05 were considered statistically significant. Continuous data were presented as means and standard deviations (SDs), whereas categorical data were summarized as frequencies and percentages. In univariate analysis, the group differences were examined with the two-sample t test or the Wilcoxon ranksum test for continuous variables and with the chi-
4 432 WEN ET AL. HEPATOLOGY, February 2011 Table 1. Clinical Characteristics of Unimmunized and Immunized HBsAg-Carrier Children Characteristic Age-Matched, Unimmunized HBsAg Carriers (n 5 214) Immunized Cases With HBV Breakthrough Infection (n 5 107) P Value Birth year * Male, n (%) 132 (61.7) 57 (53.3) Age at enrollment, years, mean 6 SD HBsAg-positive mother, n (%) 141 (65.9) 107 (100) < Positive for HBeAg at enrollment, n (%) 195 (91.1) 102 (95.3) Alanine aminotransferase at enrollment, n (%) 0.91 ULN 166 (77.6) 83 (77.6) 1-5 ULN 40 (18.7) 19 (17.8) >5 ULN 8 (3.7) 5 (4.7) Abbreviation: SD, standard deviation; ULN, upper limit of normal. *Five immunized cases with HBV breakthrough infection who were born before July 1, 1984 were the participants in the pilot study of HBIG plus hepatitis B vaccine for the prevention of perinatally transmitted HBV. For immunized cases with HBV breakthrough infection, maternal HBsAg was checked before the birth of the children; for unimmunized carriers, maternal HBsAg was checked at the time of the children s enrollment. The ULN is 40 U/L. square test or Fisher s exact test for categorical variables. The agreement between the mothers and children s HBV genotypes was analyzed with McNemar s test and the j statistic with the 95% confidence interval (CI). To assess the effect of immunization on HBV genotype distributions in children born to HBsAg-positive mothers, a multivariate logistic regression analysis that included gender, maternal age, delivery mode, and immunization as predicting variables was performed. Results Demographic and Clinical Data The demographic and clinical characteristics of 107 immunized cases with HBV breakthrough infection and 214 age-matched, unimmunized HBsAg carriers are shown in Table 1. In comparison with unimmunized carriers, more immunized cases with HBV breakthrough infection were born to HBsAg-positive mothers (65.9% versus 100%, P < 0.001). HBV Genotype Distribution, Immunization, and Maternal HBsAg Status The HBV genotype distributions in 107 immunized cases with HBV breakthrough infection were as follows: genotype B, 61 (57%); genotype C, 45 (42.1%); and mixed genotypes (B and C co-infection), 1 (0.9%). In contrast, the HBV genotype distributions in 214 agematched, unimmunized HBsAg carriers were as follows: genotype B, 177 (82.7%); genotype C, 35 (16.4%); and mixed genotypes, 2 (0.9%). The prevalence of genotype C was significantly higher in immunized cases with HBV breakthrough infection versus age-matched, unimmunized carriers (42.1% versus 16.4%, P < 0.001). Among unimmunized children, those born to HBsAg-positive mothers (n ¼ 141) and those born to HBsAg-negative mothers (n ¼ 73) had similar HBV genotype distributions (P ¼ 0.93). Figure 2 depicts the HBV genotype distributions in HBsAg-carrier children stratified by immunization and maternal HBsAg status. All the mothers of immunized cases with HBV breakthrough infection were HBsAg-positive (Table 1). As for the 214 unimmunized carriers, maternal HBsAg-seropositive rates were comparable among children with different HBV genotypes, and the rates were 65.5% for genotype B infection, 68.6% for genotype C infection, and 50% for infection with mixed genotypes (B and C; P ¼ 0.93). Mothers and Children s HBV Genotypes Maternal blood samples for HBV genotyping were available for 82 of 107 immunized cases with HBV breakthrough infection and for 91 of 141 unimmunized HBsAg carriers whose mothers were HBsAg-positive. Those mothers with HBV viral loads lower than 10 3 copies/ml were excluded because of the limitations of the genotyping method. 28 Table 2 shows the correlation of HBV genotypes in children and their HBsAg-positive mothers. A high degree of agreement was found between mothers and children s HBV genotypes in both the unimmunized group (j ¼ 0.97, 95% CI ¼ ) and the immunized group (j ¼ 0.97, 95% CI ¼ ). Secular Trend of the HBV Genotype Distribution Because the hepatitis B immunization program launched on July 1, 1984 was a national program, most immunized cases with HBV breakthrough infection and unimmunized HBsAg carriers were in
5 HEPATOLOGY, Vol. 53, No. 2, 2011 WEN ET AL. 433 unimmunized children after adjustments for gender, maternal age, and delivery mode (odds ratio ¼ 3.03, 95% CI ¼ , P ¼ 0.001; Table 4). Fig. 2. HBV genotype distribution by immunization and maternal HBsAg status. different birth cohorts (Table 1). Figure 3 shows the HBV genotype distributions in consecutive birth cohorts in unimmunized and immunized HBsAg-carrier children. For unimmunized children, HBV genotype distributions were comparable among different birth cohort groups (P ¼ 0.391). Similarly, the genotype distributions in immunized HBsAg-carrier children of different birth cohorts were also comparable (P ¼ 0.250). With respect to the maternal HBV genotype distribution in the general population in the postimmunization era, among the 136 HBsAg-positive mothers delivering babies in , 95 had a viral load higher than 10 3 copies/ml, and the HBV genotype B- infected. Among the 95 mothers, 81.1% (77/95) were genotype B infected, and 18.9% (18/95) were genotype C infected; the genotype distribution was comparable to that in the unimmunized HBsAg-carrier children (P ¼ 0.558). Effect of Immunization on the HBV Genotype Distribution Because of the high concordance between mothers and children s HBV genotypes, we assumed that all children born to HBsAg-positive mothers acquired the virus from their mothers. Table 3 lists the clinical characteristics of HBsAg-carrier children born to HBsAg-positive mothers and stratified by their HBV genotypes. By using multivariate logistic regression analysis, we found that immunized HBsAg-carrier children born to HBsAg-positive mothers had a higher likelihood of genotype C infection than Discussion In this study, the HBV genotypes identified in both immunized and unimmunized children were highly consistent with the corresponding HBsAg-positive mothers. In addition, approximately two-thirds of unimmunized HBsAg-carrier children were born to HBsAg-positive mothers, whereas all immunized cases with HBV breakthrough infection were born to HBsAg-positive mothers, regardless of the HBV genotypes. These findings suggest that mother-to-child transmission plays an important role in HBV spread in Taiwan, particularly for immunized cases with HBV breakthrough infection. Our data further provide evidence supporting the idea that both genotypes B and C can be transmitted by maternal and horizontal routes; this is somewhat different from recent speculation that genotype C is most responsible for perinatal transmission and that other genotypes (A, B, D, and F) are mainly horizontally transmitted. 21 Such speculation was raised because of the finding that HBeAg seroconversion in patients with genotype C occurred decades later than HBeAg seroconversion in patients with other genotypes. 21 Genotype C infected women were thus considered more likely to be HBeAg-positive during their childbearing years and infected their offspring at birth. Overall, whether different HBV genotypes have different transmission routes remains controversial, and further studies are needed to clarify this interesting and important issue. It is known that universal immunization with hepatitis B vaccines and HBIG beginning at birth can result in a dramatic reduction of perinatal transmission of HBV. 9 However, HBV breakthrough infection does happen on special occasions, and our data show that almost all immunized children with breakthrough infection Table 2. Comparison of HBV Genotypes Between HBsAg- Carrier Children and Corresponding HBsAg-Positive Mothers Maternal Genotype* Unimmunized HBsAg Carriers With HBsAg-Positive Mothers (n 5 72)y Immunized Cases With HBV Breakthrough Infection (n 5 74)y B(n5 51) C (n 5 21) B (n 5 43) C (n 5 31) B C *Maternal blood was collected after each child s enrollment. The list excludes 69 unimmunized and 33 immunized HBsAg-carrier children for whom the maternal blood was unavailable for HBV genotyping or the mother s HBV genotype could not be determined.
6 434 WEN ET AL. HEPATOLOGY, February 2011 Fig. 3. HBV genotype distribution by immunization and birth cohorts. *Five immunized HBsAg-positive children born before July 1984 were participants in a pilot study of HBIG plus vaccines for the prevention of HBV transmission. contracted the virus from their carrier mothers. In contrast, only two-thirds of unimmunized HBsAg carriers acquired their infection from their mothers. These facts suggest that the current universal infant immunization program not only decreases perinatal infection but also reduces horizontal HBV infection in children. Nevertheless, HBV breakthrough infection through maternal transmission remains a challenge for the global control of HBV infection. 31 Further studies to identify risk factors associated with perinatal/maternal infection despite complete immunization are required to implement a better prevention strategy for these high-risk infants. The major finding of this study is an increased ratio of genotype C to genotype B in immunized children with HBV breakthrough infection in comparison with unimmunized HBsAg carriers. However, the increased genotype C to genotype B ratio was not seen in HBsAg-carrier mothers who delivered babies in (i.e., the postimmunization era). This finding in mothers in the postimmunization era excludes the possibility that the changing HBV genotype distribution in children is related to a change in the maternal HBV genotype distribution. These lines of evidence imply that the changing HBV genotype distribution in immunized children with HBV breakthrough infection may be linked to the immunization program itself rather than a shift of genotypes in consecutive birth cohorts. Perinatal transmission of HBV is related to the maternal viral load and the mode of delivery. 32 However, in this study, maternal viral loads at the time of delivery were not available because we did not enroll the HBsAg-carrier children before or at birth. In addition to the gender of the children and the delivery mode, we used the maternal age, which was related to HBeAg seropositivity and viral loads, as a predicting variable in the multivariate logistic regression model to assess the effect of immunization on the HBV genotype distribution in HBsAg-carrier children born to carrier mothers. We did not investigate the details of the feeding practices because the breastfeeding of infants of chronic HBV carriers poses no additional risk for the transmission of HBV with appropriate immunoprophylaxis. 33 After adjustments for other factors, immunized HBsAg-carrier children born to Table 3. Clinical Characteristics of HBsAg-Carrier Children Born to HBsAg-Positive Mothers Characteristic Genotype C Infection (n 5 71)* Not Genotype C Infection (n 5 177) P Value Male, n (%) 44 (62) 98 (55.4) Maternal age at birth, years, mean 6 SD Delivered by Caesarean section, n (%) 14 (20.9) 34 (22.1) Immunized, n (%) 46 (64.8) 61 (34.5) < *This group includes 69 children with genotype C infection and 2 children coinfected with genotypes B and C. This category excludes 2 genotype C infected children and 17 genotype B infected children with missing data. This category excludes 4 genotype C infected children and 23 genotype B infected children with missing data.
7 HEPATOLOGY, Vol. 53, No. 2, 2011 WEN ET AL. 435 Table 4. Multivariate Logistic Regression Analysis of Factors Associated With Genotype C Infection in Children Born to HBsAg-Positive Mothers Variable Odds Ratio (95% CI) P Value Male 1.33 ( ) Maternal age at birth (per 1-year increase)* 1.05 ( ) Delivered by Caesarean section 0.72 ( ) Immunized 3.03 ( ) The group of patients with genotype C infection includes 69 children with genotype C infection and 2 children coinfected with genotypes B and C. *This category excludes 2 genotype C infected children and 17 genotype B infected children with missing data. This category excludes 4 genotype C infected children and 23 genotype B infected children with missing data. carrier mothers have a higher likelihood of genotype C infection than unimmunized children. Because the maternal HBV genotype distribution remained unchanged after the implementation of the immunization program, these data indicate that the rate of HBV breakthrough infection in immunized children born to genotype C mothers is higher than the rate in those born to genotype B mothers. A possible explanation is that immunization raises the threshold of the maternal viral load causing perinatal infection; thus, HBV genotype C, which is associated with higher viral loads, became predominant after the implementation of the immunization program. Because genotype C patients are known to exhibit more frequent hepatitis flares and are at greater risk of developing cirrhosis and HCC than genotype B patients, immunized children with HBV breakthrough infection (as observed in our cohort) may have a more progressive disease course that likely requires more intensive follow-up and active medical intervention in comparison with traditional, unimmunized HBsAg-carrier children. Although HBV genotype C prevails in eastern and southeastern Asia and the Pacific islands, it is not uncommon in immigrants from these areas in the United States, Europe, Australia, and New Zealand. 34 In a globalizing world in which international migration and transition are frequent, this important finding is applicable not only in Taiwan but also in the rest of the world. In summary, our results provide evidence that both HBV genotypes B and C can be transmitted from maternal and horizontal origins and that maternal transmission is responsible for most breakthrough infections in immunized HBsAg carriers. The secular trend toward an increased prevalence of genotype C indicates that immunized children born to genotype C mothers may have a higher rate of breakthrough infection than those born to genotype B mothers. These children with HBV breakthrough infection need careful, long-term follow-up, and the current immunization strategy may need modification to further eliminate the perinatal transmission of HBV. Acknowledgment: The authors thank Pei-Jer Chen and Shiou-Hwei Yeh for their professional opinion and technical support. They also thank Hui-Chuan Lee, Pei-Lin Tsai, and Shih-Ting Chiu for their help with subject follow-up and administrative work. Laboratory work performed by Cheng-Lun Chiang and De-Shiuan Su is highly appreciated. References 1. Yim HJ, Lok AS. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in HEPATOLOGY 2006; 43:S173-S Chen DS, Sung JL. Hepatitis B virus infection in Taiwan. N Engl J Med 1977;297: Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975;292: Hsu HY, Chang MH, Chen DS, Lee CY, Sung JL. Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan. J Med Virol 1986;18: Ni YH, Huang LM, Chang MH, Yen CJ, Lu CY, You SL, et al. Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology 2007;132: Kao JH, Hsu HM, Shau WY, Chang MH, Chen DS. Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan. J Pediatr 2001;139: Chen HL, Chang CJ, Kong MS, Huang FC, Lee HC, Lin CC, et al. Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination. HEPATOLOGY 2004;39: Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997;336: Beasley RP, Hwang LY, Lee GC, Lan CC, Roan CH, Huang FY, et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983;2: HsuHM,LeeSC,WangMC,LinSF,ChenDS.Efficacyofamasshepatitis B immunization program after switching to recombinant hepatitis B vaccine: a population-based study in Taiwan. Vaccine 2001;19: Chang MH, Chen TH, Hsu HM, Wu TC, Kong MS, Liang DC, et al. Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems. Clin Cancer Res 2005;11: Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, Miyakawa Y, et al. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 1988;69: Norder H, Courouce AM, Magnius LO. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 1994;198: Stuyver L, De Gendt S, Van Geyt C, Zoulim F, Fried M, Schinazi RF, et al. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 2000;81: Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO. Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol 2002;83:
8 436 WEN ET AL. HEPATOLOGY, February Kao JH, Chen PJ, Lai MY, Chen DS. Clinical and virological aspects of blood donors infected with hepatitis B virus genotypes B and C. J Clin Microbiol 2002;40: Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 2000;118: Chu CJ, Hussain M, Lok AS. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology 2002;122: Ni YH, Chang MH, Wang KJ, Hsu HY, Chen HL, Kao JH, et al. Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma. Gastroenterology 2004;127: Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, Liu CJ, et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst 2005;97: Livingston SE, Simonetti JP, Bulkow LR, Homan CE, Snowball MM, Cagle HH, et al. Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F. Gastroenterology 2007;133: Lee SD, Lo KJ, Wu JC, Tsai YT, Wang JY, Ting LP, et al. Prevention of maternal-infant hepatitis B virus transmission by immunization: the role of serum hepatitis B virus DNA. HEPATOLOGY 1986;6: LinHH,ChangMH,ChenDS,SungJL,HongKH,YoungYC,etal. Early predictor of the efficacy of immunoprophylaxis against perinatal hepatitis B transmission: analysis of prophylaxis failure. Vaccine 1991;9: Xu DZ, Yan YP, Choi BCK, Xu JQ, Men K, Zhang JX, et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol 2002;67: Wang Z, Zhang J, Yang H, Li X, Wen S, Guo Y, et al. Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies. J Med Virol 2003;71: Hsu HM, Lu CF, Lee SC, Lin SR, Chen DS. Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunization. J Infect Dis 1999;179: Naito H, Hayashi S, Abe K. Rapid and specific genotyping system for hepatitis B virus corresponding to six major genotypes by PCR using type-specific primers. J Clin Microbiol 2001;39: Yeh SH, Tsai CY, Kao JH, Liu CJ, Kuo TJ, Lin MW, et al. Quantification and genotyping of hepatitis B virus in a single reaction by realtime PCR and melting curve analysis. J Hepatol 2004;41: National Center for Biotechnology Information. BLAST. blast.ncbi.nlm.nih.gov/blast.cgi Accessed October Zhang Z, Schwartz S, Wagner L, Miller W. A greedy algorithm for aligning DNA sequences. J Comput Biol 2000;7: Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis 2002;2: Yang J, Zeng XM, Men YL, Zhao LS. Elective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus a systematic review. Virol J 2008;5: Hill JB, Sheffield JS, Kim MJ, Alexander JM, Sercely B, Wendel GD. Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers. Obstet Gynecol 2002;99: McMahon BJ. The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B. Hepatol Int 2009; 3:
Hepatitis B virus (HBV) infection is an important. Brief Communication
Brief Communication Hepatitis B Virus Infection in Children and Adolescents in a Hyperendemic Area: 15 Years after Mass Hepatitis B Vaccination Yen-Hsuan Ni, MD, PhD; Mei-Hwei Chang, MD; Li-Min Huang,
More informationIncomplete Hepatitis B Immunization, Maternal Carrier Status, and Increased Risk of Liver Diseases: A 20-Year Cohort Study of 3.8 Million Vaccinees
Incomplete Hepatitis B Immunization, Maternal Carrier Status, and Increased Risk of Liver Diseases: A 20-Year Cohort Study of 3.8 Million Vaccinees Yin-Chu Chien, 1 Chyi-Feng Jan, 2 Chun-Ju Chiang, 3 Hsu-Sung
More informationHEPATITIS B VACCINATION IN TAIWAN AND THE INCIDENCE OF HEPATOCELLULAR CARCINOMA IN CHILDREN
UNIVERSAL HEPATITIS B VACCINATION IN TAIWAN AND THE INCIDENCE OF HEPATOCELLULAR CARCINOMA IN CHILDREN MEI-HWEI CHANG, M.D., CHIEN-JEN CHEN, SC.D., MEI-SHU LAI, M.D., HSU-MEI HSU, M.P.H., TZEE-CHUNG WU,
More informationEstimation of Seroprevalence of Hepatitis B Virus and Hepatitis C Virus in Taiwan from a Large-scale Survey of Free Hepatitis Screening Participants
ORIGINAL ARTICLE Estimation of Seroprevalence of Hepatitis B Virus and Hepatitis C Virus in Taiwan from a Large-scale Survey of Free Hepatitis Screening Participants Chien-Hung Chen, 1 Pei-Ming Yang, 1
More informationHepatitis B virus (HBV) infection is a global
VIRAL HEPATITIS Serum Hepatitis B Surface Antigen Levels Help Predict Disease Progression in Patients With Low Hepatitis B Virus Loads Tai-Chung Tseng, 1,3,8 Chun-Jen Liu, 2,3 Hung-Chih Yang, 2,6 Tung-Hung
More informationRole of Hepatitis B Virus Genotypes in Chronic Hepatitis B Exacerbation
BRIEF REPORT Role of Hepatitis B Virus Genotypes in Chronic Hepatitis B Exacerbation Man-Fung Yuen, 1 Erwin Sablon, 2 Danny Ka-Ho Wong, 1 He-Jun Yuan, 1 Benjamin Chun-Yu Wong, 1 Annie On-On Chan, 1 and
More informationTwo Decades of Universal Hepatitis B Vaccination in Taiwan: Impact and Implication for Future Strategies
GASTROENTEROLOGY 2007;132:1287 1293 Two Decades of Universal Hepatitis B Vaccination in Taiwan: Impact and Implication for Future Strategies YEN HSUAN NI,* LI MIN HUANG,* MEI HWEI CHANG,* CHUNG JEN YEN,
More informationHepatitis B surface antigen HBsAg Hepatitis B e antigen HBeAg 1) B
292 14 4 B Effects of the Vaccination Against Hepatitis B Virus for All Infants in Taiwan Chang-Kuen Tien, Nobutaka Kurihara, Hiroyuki Yanagisawa and Osamu Wada (Hygiene and Preventive Medicine, Saitama
More informationMore than 350 million persons worldwide are chronically
GASTROENTEROLOGY 2007;133:1452 1457 Clearance of Hepatitis B e Antigen in Patients With Chronic Hepatitis B and s A, B, C, D, and F STEPHEN E. LIVINGSTON,* JOSEPHINE P. SIMONETTI,* LISA R. BULKOW, CHRISS
More informationAlthough substantial progress has been made in
VIRAL HEPATITIS Waning Immunity to Plasma-Derived Hepatitis B Vaccine and the Need for Boosters 15 Years After Neonatal Vaccination Chun-Yi Lu, 1 Bor-Luen Chiang, 1,2 Wei-Kuang Chi, 3 Mei-Hwei Chang, 1
More informationGlobal Perspective on the Natural History of Chronic Hepatitis B: Role of Hepatitis B Virus Genotypes A to J
97 Global Perspective on the Natural History of Chronic Hepatitis B: Role of Hepatitis B Virus Genotypes A to J Chun-Jen Liu, MD, PhD 1,2,3 Jia-Horng Kao, MD, PhD 1,2,3,4 1 Graduate Institute of Clinical
More informationNatural History of HBV Infection
Natural History of HBV Infection Joseph JY Sung MD PhD Institute of Digestive Disease Department of Medicine & Therapeutics Prince of Wales Hospital The Chinese University of Hong Kong HBV Infection 2
More informationSupplementary materials: Predictors of response to pegylated interferon in chronic hepatitis B: a
Supplementary materials: Predictors of response to pegylated interferon in chronic hepatitis B: a real-world hospital-based analysis Yin-Chen Wang 1, Sien-Sing Yang 2*, Chien-Wei Su 1, Yuan-Jen Wang 3,
More informationUniversal immunization beginning at birth and
AMERICAN ASSOCIATION FOR THE STUDY OFLIVERD I S E ASES HEPATOLOGY, VOL. 64, NO. 5, 2016 Quantitative Maternal Hepatitis B Surface Antigen Predicts Maternally Transmitted Hepatitis B Virus Infection Wan-Hsin
More informationHepatitis B vaccine alone or with HBIG in neonates of HBsAg+/HBeAg- mothers: a systematic review and meta-analysis.
Hepatitis B vaccine alone or with HBIG in neonates of HBsAg+/HBeAg- mothers: a systematic review and meta-analysis. Vana Papaevangelou (Greece) National and Kapodistrian University of Athens Chang SemFNM
More informationThe Hepatitis B Vaccine: What Went Wrong?
The Hepatitis B Vaccine: What Went Wrong? By F. Edward Yazbak, MD, FAAP On Dec. 23, 2005, the Centers for Disease Control and Prevention (CDC) published a Morbidity and Mortality Weekly Report (1) in which
More informationWhat have we learned from HBV clinical cohorts?
PHC 2015: Hepatitis B What have we learned from HBV clinical cohorts? Jia-Horng Kao MD, Ph D Graduate Institute of Clinical Medicine, Hepatitis Research Center, Department of Internal Medicine, National
More informationEpatite B: fertilità, gravidanza ed allattamento, aspetti clinici e terapeutici. Ivana Maida
Epatite B: fertilità, gravidanza ed allattamento, aspetti clinici e terapeutici Ivana Maida Positivity for HBsAg was found in 0.5% of tested women In the 70s and 80s, Italy was one of the European countries
More informationHepatitis B Update. Jorge L. Herrera, M.D. University of South Alabama Mobile, AL. Gastroenterology
Hepatitis B Update Jorge L. Herrera, M.D. University of South Alabama Mobile, AL Deciding Who to Treat Is hepatitis B a viral disease or a liver disease? Importance of HBV-DNA Levels in the Natural History
More informationKey words: HBV, Taiwan, epidemiology, vaccination program, hepatitis B vaccine
Original Article 521 Forecasting the Declining Rate of Chronic Hepatitis- Carrier Status at a Taiwanese University: Twenty Years after Implementation of an Universal HV Vaccination Program in Taiwan Fu-Hsiung
More informationUniversal hepatitis B (HB) immunization has
Determination of Immune Memory to Hepatitis B Vaccination Through Early Booster Response in College Students Chyi-Feng Jan, 1,2 Kuo-Chin Huang, 1 Yin-Chu Chien, 3 Donald E. Greydanus, 2 H. Dele Davies,
More informationChronic hepatitis B virus (HBV) infection remains a major
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2010;8:541 545 Hepatitis B Virus DNA Level Predicts Hepatic Decompensation in Patients With Acute Exacerbation of Chronic Hepatitis B WEN JUEI JENG, I SHYAN SHEEN,
More informationTo test the possible source of the HBV infection outside the study family, we searched the Genbank
Supplementary Discussion The source of hepatitis B virus infection To test the possible source of the HBV infection outside the study family, we searched the Genbank and HBV Database (http://hbvdb.ibcp.fr),
More informationPERINATAL HEPATIDES AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) Pamela Palasanthiran Staff Specialist, Paediatric Infectious Diseases
PERINATAL HEPATIDES AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) Pamela Palasanthiran Staff Specialist, Paediatric Infectious Diseases Viruses in July (ViJ), 2004 Overview Epidemiology Perinatal transmission
More informationDecreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study
ARTICLE Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study Mei-Hwei Chang, San-Lin You, Chien-Jen Chen, Chun-Jen Liu, Chuan-Mo Lee, Shi-Ming Lin, Heng-Cheng
More informationY. Xiang*, P. Chen*, J.R Xia and L.P. Zhang
A large-scale analysis study on the clinical and viral characteristics of hepatitis B infection with concurrence of hepatitis B surface or E antigens and their corresponding antibodies Y. Xiang*, P. Chen*,
More informationHEPATITIS B: PREGNANCY AND LABOR MANAGEMENT MICHAEL P. NAGEOTTE, M.D.
HEPATITIS B: PREGNANCY AND LABOR MANAGEMENT MICHAEL P. NAGEOTTE, M.D. Disclosures I have no relevant financial relationships to disclose or conflicts of interest to resolve. I will not discuss any unapproved
More informationHepatitis B Virus in Pregnancy
REVIEW REVIEW Hepatitis B Virus in Pregnancy Tram T. Tran, M.D. Chronic hepatitis B virus (HBV) infection remains an important worldwide cause of chronic liver disease, which may lead to the development
More informationHBsAg(+) mothers is a transient
Perinatal HBV viremia in newborns of HBsAg(+) mothers is a transient phenomenon that does not necessarily imply HBV infection transmission Vana Papaevangelou (Greece) National and Kapodistrian University
More informationuniversal vaccination
Vol. 21No. 2149 8 HB B universal vaccination Blumberg HBs B 40 B HBV HBV HBV HBs WHO 1992 HBV B HB universal vaccination 1997 HB universal vaccination HBV high risk HBV universal vaccination B HBV universal
More informationManagement of Chronic Hepatitis B in Asian Americans
Management of Chronic Hepatitis B in Asian Americans Myron J Tong; UCLA, CA Calvin Q. Pan; Mount Sinai, NY Hie-Won Hann; Thomas Jefferson, PA Kris V. Kowdley; Virginia Mason, WA Steven Huy B Han; UCLA,
More informationB C ALT B C B B C
2006 17 276-290 520 ( Hepatitis surface antigen, HsAg ) ( Anti-hepatitis virus antibody anti-hv ) ( alanine transaminase ) 2004 4 11 31 533 216 (n=56702; / : 17551/39151) HsAg anti-hv 40 IU/L (standardized
More informationCURRENT TREATMENT. Mitchell L Shiffman, MD Director Liver Institute of Virginia Bon Secours Health System Richmond and Newport News, Virginia
CURRENT TREATMENT OF HBV Mitchell L Shiffman, MD Director Liver Institute of Virginia Bon Secours Health System Richmond and Newport News, Virginia CHRONIC HBV INFECTION DEMOGRAPHICS IN THE USA Estimated
More informationViral Hepatitis. Dr Melissa Haines Gastroenterologist Waikato Hospital
Viral Hepatitis Dr Melissa Haines Gastroenterologist Waikato Hospital Viral Hepatitis HAV HBV HCV HDV HEV Other viral: CMV, EBV, HSV Unknown Hepatitis A Hepatitis A Transmitted via the faecal-oral route
More informationChronic infection with hepatitis B virus (HBV) is still a
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2012;10:527 534 Incidence and Determinants of Spontaneous Hepatitis B e Antigen and DNA in Patients With Chronic Hepatitis B HWAI I YANG,*,, HSIU LIAN HUNG, MEI
More informationEpidemiology of hepatitis E infection in Hong Kong
RESEARCH FUND FOR THE CONTROL OF INFECTIOUS DISEASES Epidemiology of hepatitis E infection in Hong Kong DPC Chan *, KCK Lee, SS Lee K e y M e s s a g e s 1. The overall anti hepatitis E virus (HEV) seropositivity
More informationSummary of Seroprotection after Recombinant Hepatitis B Vaccine Administered to Newborn Infants (defined as the first 30 days of Life) Background:
Prepared by: TV Murphy, MD, September 16, 2016 Summary of Seroprotection after Recombinant Hepatitis B Vaccine Administered to Newborn Infants (defined as the first 30 days of Life) Background: The primary
More informationThe Evolving Landscape of Preventing Maternal-Fetal Hepatitis B Infections
The Evolving Landscape of Preventing Maternal-Fetal Hepatitis B Infections Neil S. Silverman, M.D. Center for Fetal Medicine and Women s Ultrasound Clinical Professor, Obstetrics/Gynecology David Geffen
More informationDepartment of Public Health, Taipei Medical University, Taipei City, Taiwan
Page 1 of 30 1 TITLE PAGE Title: Chronic hepatitis B infection in adolescents who had received primary infantile vaccination. Authors and affiliations Tzu-Wei Wu 1,*, Hans Hsienhong Lin 2,3*, Li-Yu Wang
More informationViral Hepatitis in Reproductive Health
Viral Hepatitis in Reproductive Health Training Course in Sexual and Reproductive Health Research Geneva 2010 Dr José M Bengoa Dr Pierre Jean Malè Consultants Division of Gastroenterology and Hepatology
More informationDetection Different of Genotypes of Hepatitis B virus by Using Genotype- Specific Primers and its Clinical Correlation
ORIGINAL ARTICLE Detection Different of Genotypes of Hepatitis B virus by Using Genotype- Specific Primers and its Clinical Correlation *RUBINA GHANI, HIRA JAVED, HAMZA ALI, MUHAMMAD USMAN, KANWAL SABA,
More informationElimination of Perinatal Hepatitis B Transmission
Elimination of Perinatal Hepatitis B Transmission Trudy V. Murphy, MD Division of Viral Hepatitis NCHHSTP, CDC December 19, 2013 Hep B United and WHIAAPI Webinar Background q Hepatitis B is an infection
More informationAN ECONOMIC EVALUATION OF UNIVERSAL INFANT VACCINATION STRATEGIES AGAINST HEPATITIS B IN THAILAND: AN ANALYTIC DECISION APPROACH TO COST-EFFECTIVENESS
AN ECONOMIC EVALUATION OF UNIVERSAL INFANT VACCINATION STRATEGIES AGAINST HEPATITIS B IN THAILAND: AN ANALYTIC DECISION APPROACH TO COST-EFFECTIVENESS Thosporn Vimolket 1 and Yong Poovorawan 2 1 Department
More informationHepatitis B virus (HBV) infection is a global. Chronic Hepatitis B Infection in Adolescents Who Received Primary Infantile Vaccination
Chronic Hepatitis B Infection in Adolescents Who Received Primary Infantile Vaccination Tzu-Wei Wu, 1 * Hans Hsienhong Lin, 2,3 * and Li-Yu Wang 1,4 Hepatitis B virus (HBV) infection is a global health
More informationThe Hep B Moms Program: A Primary Care Model for Management of Hepatitis B in Pregnancy
The Hep B Moms Program: A Primary Care Model for Management of Hepatitis B in Pregnancy Janice Lyu, MS Senior Hepatitis B Program Associate Charles B. Wang Community Health Center (CBWCHC) Charles B Wang
More informationEpidemiology and Natural History of Hepatitis B in Children
Epidemiology and Natural History of Hepatitis B in Children Szu-Ta Chen and Mei-Hwei Chang Key Concepts Patients in countries with high HBV endemicity tend to have perinatal transmission of hepatitis B,
More informationClinical Management of Hepatitis B WAN-CHENG CHOW DEPARTMENT OF GASTROENTEROLOGY & HEPATOLOGY SINGAPORE GENERAL HOSPITAL
Clinical Management of Hepatitis B WAN-CHENG CHOW DEPARTMENT OF GASTROENTEROLOGY & HEPATOLOGY SINGAPORE GENERAL HOSPITAL The World Health Organisation recent initiatives on HBV infection Launching of the
More informationTreatment of hepatitis B : the guidelines and real life
Treatment of hepatitis B : the guidelines and real life Prince of Songkla University, Thailand Teerha Piratvisuth MD. NKC Institute of Gastroenterology and Hepatology Disclosure Statement of Financial
More informationHepatitis B Disease Burden: A Model for Global Estimates and Impact of Vaccination. Susan A. Wang, MD, MPH Division of Viral Hepatitis
Hepatitis B Disease Burden: A Model for Global Estimates and Impact of Vaccination Susan A. Wang, MD, MPH Division of Viral Hepatitis Barriers to Appreciating HBV Disease Burden and Vaccine Impact Chronic
More informationViral hepatitis and Hepatocellular Carcinoma
Viral hepatitis and Hepatocellular Carcinoma Hashem B. El-Serag, MD, MPH Dan L. Duncan Professor of Medicine Chief, Gastroenterology and Hepatology Houston VA & Baylor College of Medicine Houston, TX Outline
More informationNATURAL HISTORY OF HEPATITIS B
NATURAL HISTORY OF HEPATITIS B AND DIAGNOSTIC: STATE OF THE ART O. BAHRI LABORATORY OF MEDICAL BIOLOGY AZIZA OTHMANA HOSPITAL TUNIS, TUNISIA The 2 nd Congress of The Federation of Arab Societies of Clinical
More informationHepatitis and pregnancy
Hepatitis and pregnancy Pierre-Jean Malè MD Training Course in Reproductive Health Research WHO Geneva 2008 26.02.2008 Liver disease and pregnancy: three possible etiologic relationship the patient has
More informationHIGH RATE OF HEPATITIS B VIRUS MOTHER-TO-CHILD TRANSMISSION IN LAO PEOPLE S DEMOCRATIC REPUBLIC
HIGH RATE OF HEPATITIS B VIRUS MOTHER-TO-CHILD TRANSMISSION IN LAO PEOPLE S DEMOCRATIC REPUBLIC Prapan Jutavijittum 1, Amnat Yousukh 1, Bounnack Saysanasongkham 2, Bounthome Samountry 3, Khamtim Samountry
More informationE pidemiological studies have shown a strong association
1494 LIVER Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma H L-Y Chan, A Y Hui, M L Wong, A M-L Tse, L C-T Hung, V W-S Wong, J J-Y Sung... See end
More informationART ICLEHepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men
ART ICLEHepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men Ming-Whei Yu, Shiou-Hwei Yeh, Pei-Jer Chen, Yun-Fan Liaw, Chih-Lin Lin, Chun-Jen Liu, Wei-Liang
More informationHepatitis B Virus Genotypes: Clinical Implications
Hepatitis B Virus Genotypes : Clinical Implications Subrat Kumar Acharya, Yogesh Batra Professor, Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi 110 029 87 Introduction
More informationA study on hepatitis-b in pregnant women and their neonatal outcome
International Journal of Medical and Health Research ISSN: 2454-9142, Impact Factor: RJIF 5.54 www.medicalsciencejournal.com Volume 3; Issue 2; February 2017; Page No. 126-130 A study on hepatitis-b in
More informationMore than 2 billion people in the world are infected
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2004;2:941 945 18-Year Follow-up Study of a Prospective Randomized Trial of Hepatitis B Vaccinations Without Booster Doses in Children MAN FUNG YUEN,* WEI LING
More informationChronic hepatitis B virus (HBV) infection affects
GASTROENTEROLOGY 2009;136:505 512 Predictive Factors for Early HBeAg Seroconversion in Acute Exacerbation of Patients With HBeAg-Positive Chronic Hepatitis B HYOUNG SU KIM,* HA JUNG KIM, WOON GEON SHIN,*
More informationNatural History of Chronic Hepatitis B
Natural History of Chronic Hepatitis B Anna SF Lok, MD Alice Lohrman Andrews Professor in Hepatology Director of Clinical Hepatology Assistant Dean for Clinical Research University of Michigan Ann Arbor,
More informationObstetricians and gynecologists knowledge, education, and practices regarding chronic hepatitis B in pregnancy
ORIGINAL ARTICLE Annals of Gastroenterology (2017) 30, 670-674 Obstetricians and gynecologists knowledge, education, and practices regarding chronic hepatitis B in pregnancy Bolin Niu a, Dina Halegoua-De
More informationChronic hepatitis B (CHB) infection is a large
AMERICAN ASSOCIATION FOR THE STUDY OFLIVERD I S E ASES HEPATOLOGY, VOL. 64, NO. 2, 2016 Serum Levels of Hepatitis B Surface Antigen and DNA Can Predict Inactive Carriers With Low Risk of Disease Progression
More informationMAJOR ARTICLE JID 2008:198 (1 December) Chen et al.
MAJOR ARTICLE Combined Mutations in Pre-S/Surface and Core Promoter/Precore Regions of Hepatitis B Virus Increase the Risk of Hepatocellular Carcinoma: A Case-Control Study Chien-Hung Chen, 1,2 Chi-Sin
More informationChoice of Oral Drug for Hepatitis B: Status Asokananda Konar
Choice of Oral Drug for Hepatitis B: Status 2011 Asokananda Konar Chronic hepatitis B (CHB) is a global public health challenge with an estimated 350 to 400 million people with chronic HBV infection, despite
More informationHBV Core and Core-Related Antigen Quantitation in Chinese Patients with. Chronic Hepatitis B Genotype B and C Virus Infection
Title page HBV Core and Core-Related Antigen Quantitation in Chinese Patients with Chronic Hepatitis B Genotype B and C Virus Infection Short Title: Quantitation of HBc and HBcrAg in Chinese patients Akinori
More informationViral Hepatitis Diagnosis and Management
Viral Hepatitis Diagnosis and Management CLINICAL BACKGROUND Viral hepatitis is a relatively common disease (25 per 100,000 individuals in the United States) caused by a diverse group of hepatotropic agents
More informationHepatitis B virus (HBV) infection can cause
Prevention of Hepatitis B Mei-Hwei Chang 1,2 and Ding-Shinn Chen 2,3,4 1 Department of Pediatrics, National Taiwan University Hospital, Taipei 10016, Taiwan 2 Hepatitis Research Center, National Taiwan
More informationHBV in New Zealand Community HBV screening to long-term follow-up
HBsAg+ icteric hepatitis (n) % anti-hbcore+ 26/9/214 HBV in New Zealand Community HBV screening to long-term follow-up John Hornell, CEO, A registered charitable trust whose mission is: To improve health
More informationIL10 rs polymorphism is associated with liver cirrhosis and chronic hepatitis B
IL10 rs1800896 polymorphism is associated with liver cirrhosis and chronic hepatitis B L.N. Cao 1, S.L. Cheng 2 and W. Liu 3 1 Kidney Disease Department of Internal Medicine, Xianyang Central Hospital,
More informationHepatitis B. What's the impact on the risk? Dr Himanshu Bhatia, Asia Chief Medical Officer ALUCA, Brisbane, Sept 2013
Hepatitis B What's the impact on the risk? Dr Himanshu Bhatia, Asia Chief Medical Officer ALUCA, Brisbane, Sept 2013 Some quick facts about Hepatitis B Worldwide: 350-400 Million are chronic infections
More informationSummary of Key Points. WHO Position Paper on Vaccines against Hepatitis B, July 2017
Summary of Key Points WHO Position Paper on Vaccines against Hepatitis B, July 2017 1 Background l HBV is transmitted by exposure of mucosal membranes or non-intact skin to infected blood, saliva, semen
More informationHepatitis B Virus Mutation in Children
59 Symposium on Hepatology and Gastroenterology-II Hepatitis B Virus Mutation in Children Mei-Hwei Chang Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan ABSTRACT Due to the
More informationEAST LONDON INTEGRATED CARE
CITY & HACKNEY ELIC EAST LONDON INTEGRATED CARE MANAGEMENT OF CHRONIC HEPATITIS B IN PRIMARY CARE Chronic Hepatitis B virus (HBV) is an important public health problem globally and a leading cause of liver
More informationHepatitis B: A Preventable Cause of Liver Cancer. Saira Khaderi MD, MPH Assistant Professor of Surgery Associate Director, Project ECHO June 17, 2016
Hepatitis B: A Preventable Cause of Liver Cancer Saira Khaderi MD, MPH Assistant Professor of Surgery Associate Director, Project ECHO June 17, 2016 Overview Epidemiology HBV and cancer Screening, Diagnosis
More informationC hronic hepatitis B (CHB) virus infection affects more
161 HEPATITIS Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications MF Yuen, HJ Yuan, D KH Wong, J CH Yuen, WM Wong, A OO Chan, B CY Wong, KC Lai, CL Lai... See end of article
More informationCarrier state and chronic infection state. At-risk populations
John T. Stutts, MD, MPH University of Louisville School of Medicine Department of Pediatrics Division of Pediatric Gastroenterology, Hepatology and Nutrition Carrier state and chronic infection state -
More informationHumoral and Cellular Immune Responses to a Hepatitis B Vaccine Booster Years after Neonatal Immunization
MAJOR ARTICLE Humoral and Cellular Immune Responses to a Hepatitis B Vaccine Booster 15 18 Years after Neonatal Immunization Chun-Yi Lu, 1 Yen-Hsuan Ni, 1 Bor-Luen Chiang, 1 Pei-Jer Chen, 2 Mei-Hwei Chang,
More informationPhylogenetic, Virological, and Clinical Characteristics of Genotype C Hepatitis B Virus with TCC at Codon 15 of the Precore Region
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 2006, p. 681 687 Vol. 44, No. 3 0095-1137/06/$08.00 0 doi:10.1128/jcm.44.3.681 687.2006 Copyright 2006, American Society for Microbiology. All Rights Reserved. Phylogenetic,
More informationCITY & HACKNEY ELIC EAST LONDON INTEGRATED CARE MANAGEMENT OF CHRONIC HEPATITIS B IN PRIMARY CARE
CITY & HACKNEY ELIC EAST LONDON INTEGRATED CARE MANAGEMENT OF CHRONIC HEPATITIS B IN PRIMARY CARE Chronic Hepatitis B virus (HBV) is an important public health problem globally and a leading cause of liver
More informationHBV vaccination: Optimizing coverage and efficacy. Alex Vorsters, Pierre Van Damme Viral Hepatitis Prevention Board
HBV vaccination: Optimizing coverage and efficacy. Alex Vorsters, Pierre Van Damme Viral Hepatitis Prevention Board 2 nd Hepatitis Cure and Eradication Meeting 11 12 November 2015 Declaration of Interest
More informationThe Impact of HBV Therapy on Fibrosis and Cirrhosis
The Impact of HBV Therapy on Fibrosis and Cirrhosis Jordan J. Feld, MD, MPH Associate Professor of Medicine University of Toronto Hepatologist Toronto Centre for Liver Disease Sandra Rotman Centre for
More informationHepatitis B Virus Genotype C Is Associated With More Severe Liver Fibrosis Than Genotype B
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2009;7:1361 1366 Hepatitis B Virus Is Associated With More Severe Liver Fibrosis Than HENRY LIK YUEN CHAN, GRACE LAI HUNG WONG, CHI HANG TSE, ANGEL MEI LING CHIM,
More informationHepatitis B Virus Genotype B Is Associated With Earlier HBeAg Seroconversion Compared With Hepatitis B Virus Genotype C
GASTROENTEROLOGY 2002;122:1756 1762 Hepatitis B Virus Genotype B Is Associated With Earlier HBeAg Seroconversion Compared With Hepatitis B Virus Genotype C CHI JEN CHU, MUNIRA HUSSAIN, and ANNA S. F. LOK
More informationPerinatal Hepatitis b Prevention
Perinatal Hepatitis b Prevention Purpose 2 The primary goal of the Perinatal Hepatitis b Prevention Program (PHBPP) is to identify all pregnant women who are infected with hepatitis b and prevent perinatal
More informationHepatitis B (Hep-B) is one of the most
Paediatrica Indonesiana VOLUME 50 November NUMBER 6 Original Article Influence of Hepatitis B immunization to prevent vertical transmission of Hep-B virus in infants born from Hep-B positive mother Liza
More informationEpidemiology of Hepatitis B in sub-saharan Africa. 7 February 2018 Yusuke Shimakawa, MD, PhD Institut Pasteur
Epidemiology of Hepatitis B in sub-saharan Africa 7 February 2018 Yusuke Shimakawa, MD, PhD Institut Pasteur From the Big Three to the Big Four 1600000 Number of deaths/year 1400000 HAV + HEV 1200000 1000000
More informationChing-Wen Wang, Li-Chieh Wang, Mei-Hwei Chang,* Yen-Hsuan Ni, Huey-Ling Chen, Hong-Yuan Hsu, and Ding-Shin Chen
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, Dec. 2005, p. 1442 1447 Vol. 12, No. 12 1071-412X/05/$08.00 0 doi:10.1128/cdli.12.12.1442 1447.2005 Copyright 2005, American Society for Microbiology. All
More informationHEPATITIS B: are escape mutants of concern?
VACCINATION: AN EVOLUTIONARY ENGINE FOR SPECIES? Fondation Mérieux Conference Centre Veyrier-du-Lac, France November 25-27, 2013 HEPATITIS B: are escape mutants of concern? Alessandro ZANETTI Department
More informationNHS public health functions agreement
NHS public health functions agreement 2016-17 Service specification No.1 Neonatal hepatitis B immunisation programme Classification: official NHS England INFORMATION READER BOX Directorate Medical Commissioning
More informationHBV NATURAL HISTORY. Mitchell L. Shiffman, MD Director Liver Institute of Virginia Bon Secours Health System Richmond and Newport News, Virginia
HBV NATURAL HISTORY AND MANAGMENT Mitchell L. Shiffman, MD Director Liver Institute of Virginia Bon Secours Health System Richmond and Newport News, Virginia IVer Liver Institute of Virginia Education,
More informationHepatitis B virus infection. Chow Wan Cheng Dept of Gastroenterology & Hepatology Singapore General Hospital
Hepatitis B virus infection Chow Wan Cheng Dept of Gastroenterology & Hepatology Singapore General Hospital Chronic Hepatitis B - are we in the same situation as hepatitis C? Treatment of chronic hepatitis
More informationSerum Hepatitis B Surface Antigen Levels Help Predict Disease Progression in Patients With Low Hepatitis B Virus Loads. Hepatology Feb 2013
Serum Hepatitis B Surface Antigen Levels Help Predict Disease Progression in Patients With Low Hepatitis B Virus Loads Hepatology Feb 2013 Hepatitis B Surface Antigen HBsAg is the glycosylated envelope
More informationMutants and HBV vaccination. Dr. Ulus Salih Akarca Ege University, Izmir, Turkey
Mutants and HBV vaccination Dr. Ulus Salih Akarca Ege University, Izmir, Turkey Geographic Distribution of Chronic HBV Infection 400 million people are carrier of HBV Leading cause of cirrhosis and HCC
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Pan CQ, Duan Z, Dai E, et al. Tenofovir to prevent hepatitis
More informationLong-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men
Carcinogenesis vol.29 no.1 pp.106 112, 2008 doi:10.1093/carcin/bgm252 Advance Access publication November 13, 2007 Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular
More informationHepadnaviridae family (DNA) Numerous antigenic components Humans are only known host May retain infectivity for more than 7 days at room temperature
Hepatitis B Epidemic jaundice described by Hippocrates in 5th century BC Jaundice reported among recipients of human serum and yellow fever vaccines in 1930s and 1940s Australia antigen described in 1965
More informationS ince effective vaccines against hepatitis B became
1499 LIVER Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan H-Y Hsu, M-H Chang, Y-H Ni, H-L Chen... See end of article for authors
More informationSTATE TDAP VACCINE PROGRAM
STATE TDAP VACCINE PROGRAM CDPH provides free Tdap vaccine for local public health departments. This vaccine then is distributed to clinics through out county. Vaccine to be specifically given to: Woman
More informationMA PERINATAL HEPATITIS B PREVENTION PROGRAM
MA PERINATAL HEPATITIS B PREVENTION PROGRAM Massachusetts Department of Public Health Immunization Program MIAP 2016 1 1 Presenter Disclosure Information I, Theodora Wohler, have been asked to disclose
More informationCornerstones of Hepatitis B: Past, Present and Future
Cornerstones of Hepatitis B: Past, Present and Future Professor Man-Fung Yuen Queen Mary Hospital The University of Hong Kong Hong Kong 1 Outline Past Natural history studies Development of HBV-related
More information